GPC1 and esophageal squamous cell carcinoma: Moreover, GPC1 was found to be expressed in lymph node metastases (Figure 1B), suggesting that systemic treatment with anti-GPC1 mAb may also have efficacy in patients with lymph node ESCC metastases.